Publication:
Treatment of men with oligoasthenozoospermia and asthenozoospermia with kallikrein

Simple item page
dc.contributor.authorMicic, S. (7006493137)
dc.contributor.authorBila, S. (7004379936)
dc.contributor.authorIlic, V. (7006666131)
dc.contributor.authorSulovic, V. (7006602555)
dc.date.accessioned2025-06-12T11:58:15Z
dc.date.available2025-06-12T11:58:15Z
dc.date.issued1985
dc.description.abstractA randomised group of 75 men with idiopathic oligoasthenozoospermia and asthenozoospermia were subjected to a control study with kallikrein. Kallikrein was given to 45 men, 600 units daily in a period of 3-6 months. The other group of 30 infertile men was followed during the same period of time. Percentage of motile sperm was significantly improved after 3-6 months' treatment with kallikrein. Sperm count and percentage of morphologically normal sperm showed improvement but this was not statistically significant. Infertile men with a sperm count below 20 x 106/ml had greater improvement in sperm count than men with a sperm count over 20 x 106/ml. This study emphasizes that kallikrein is a relatively good drug for restoring sperm motility in idiopathic oligoasthenozoospermia and asthenozoospermia.
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0021850158&partnerID=40&md5=324616ad80378338f398f071b99cd9ab
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/2080
dc.titleTreatment of men with oligoasthenozoospermia and asthenozoospermia with kallikrein
dspace.entity.typePublication

Files

Collections

Publikacije / Publications